5,6-Di-substituted oxadiazolopyrazines and thiadiazolopyrazines as CXC-chemokine receptor ligands
申请人:Biju J. Purakkattle
公开号:US20070015731A1
公开(公告)日:2007-01-18
Disclosed are compounds of the formula
and the pharmaceutically acceptable salts thereof. The compounds are useful for the treatment of chemokine-mediated diseases such as COPD.